FAQ

Zanamivir

Known as: ATC code J05AH01, ATCvet code QJ05AH01, Relenza 
Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It… (More)
Wikipedia

Topic mentions per year

Topic mentions per year

1999-2017
05101519992017

Related topics

Related topics

1 relation

Broader (1)

Computational chemistry

Related mentions per year

Related mentions per year

1963-2018
1960198020002020
Zanamivir
Computational chemistry

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs
Influenza virus spreads infection by two main surface glycoproteins, namely hemagglutinin (HA) and neuraminidase (NA). NA cleaves… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • figure 2
Is this relevant?
2016
2016
The inhibition of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with zanamivir
As one of the most effective drugs for influenza virus infection, clinical application of zanamivir is restricted with the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation…
Since late March 2013, there has been another global health concern with a sudden wave of flu infections by a novel strain of… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2012
2012
NICE and Relenza — the saga continues
  • International Journal of Pharmaceutical Medicine
  • 2012
 
Is this relevant?
2012
2012
NICE and Relenza — the saga continues (2)
  • International Journal of Pharmaceutical Medicine
  • 2012
 
Is this relevant?
2009
2009
Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study
In the context of the recent pandemic threat by the worldwide spread of H5N1 avian influenza, novel insights into the mechanism… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
2008
2008
Polar biotech
 
  • table 1
Is this relevant?
2000
2000
“NICE” bald auch in Deutschland.
  • HEPAC Health Economics in Prevention and Care
  • 2000
 
Is this relevant?
2000
2000
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
  • G. H AYDEN, LBERT D. M. E. O STERHAUS, +5 authors K EVIN W IGHTMAN
  • 2000
A BSTRACT Background The sialic acid analogue zanamivir (GG167) is a selective inhibitor of influenza A and B virus… (More)
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1999
1999
Erratum: Bundesgesundheitsblatt (1998) 41,4:157–163
  • Bundesgesundheitsblatt - Gesundheitsforschung…
  • 1999
 
Is this relevant?